PVLA
PALVELLA THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$150.56
−2.44%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-28.4%
Return on equity
-24.3%
Return on assets
-26.6%
Return on invested capital
0.00x
Asset turnover
-$36.5M
Cash from operations
$17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026